Future Outlook of the Hormonal Intrauterine Devices (IUDs) Market: Growth, Trends, and Emerging Opportunities Explored
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the hormonal intrauterine devices (iuds) market right now?
The hormonal intrauterine devices (IUDs) market has seen rapid growth, rising from $2.61 billion in 2024 to $2.89 billion in 2025, at a CAGR of 11.0%. Factors contributing to past growth include improvements in hormonal formulations, increased demand for long-term contraceptive solutions, more healthcare provider recommendations, greater awareness of birth control options, and advancements in medical technology and device design.
How fast Is the hormonal intrauterine devices (iuds) market expected to grow, and what’s its future value?
The hormonal intrauterine devices (IUDs) market is projected to expand quickly, reaching $4.34 billion by 2029 at a CAGR of 10.7%. Growth will be driven by rising contraceptive awareness, preference for long-acting reversible birth control, improvements in device safety and effectiveness, focus on personalized healthcare, and wider availability through healthcare providers. Major trends include advancements in device technology, increasing personalization of contraceptive choices, patient-centric healthcare, demand for sustainable products, and the introduction of new contraceptive solutions.
Get your hormonal intrauterine devices (iuds) market report here!
What are the leading drivers of growth in the hormonal intrauterine devices (iuds) market?
The increasing rate of unwanted pregnancies is expected to drive the growth of the hormonal intrauterine devices (IUD) market. Unwanted pregnancies, often resulting from contraceptive failure or lack of access to birth control, create a need for highly effective contraceptive solutions. Hormonal IUDs offer long-term pregnancy prevention with a failure rate of less than 1%. In August 2023, the Office for Health Improvement & Disparities in the UK reported a 17% rise in abortions from January to June 2022 compared to the previous year, indicating higher demand for hormonal IUDs.
What are the key segments defining the hormonal intrauterine devices (iuds) market?
The hormonal intrauterine devices (IUDs) market covered in this report is segmented –
1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices
3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications
Subsegments:
1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp
Who are the key players steering the development of the hormonal intrauterine devices (iuds) market?
Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare
What emerging trends are influencing the growth of the hormonal intrauterine devices (iuds) market?
Leading organizations in the hormonal intrauterine devices market, such as levonorgestrel-releasing intrauterine systems, are focusing their efforts on the development of state-of-the-art products to provide more personalized contraceptive methods for females. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal intrauterine devices that discharge a regulated amount of levonorgestrel, an artificial progestin, into the uterus. This hormone enhances the thickness of cervical mucus and modifies the lining of the uterus to stop sperm from reaching the egg. For instance, Medicines360, a pharmaceutical firm based in the U.S. dedicated to enhancing women’s access to necessary medicines and health products, launched the U.S. Food and Drug Administration (FDA)-approved LILETTA in November 2022. LILETTA is one of the longest-lasting hormonal IUDs in the U.S., approved for up to 8 years for contraception and up to 5 years for the treatment of heavy menstrual bleeding. It boasts an efficacy rate of approximately 99% in preventing pregnancy among varied demographics. This device is designed with an ergonomic inserter for straightforward placement on the consultative day and can be removed by a healthcare professional at any time. It is available through prescription, and its cost is reduced via the 340B drug pricing program, a significant move in line with Medicines360’s goal of enhancing women’s healthcare access.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19091
Which regions are most influential in expanding the hormonal intrauterine devices (iuds) market?
North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Hearing Aid Devices And Equipment Global Market Report 2024
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Hearing Diagnostic Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
